secwatch.observer — SEC 8-K summary
======================================

Issuer:     TANDEM DIABETES CARE INC (TNDM)
CIK:        0001438133
Form:       8-K
Filed at:   2025-05-12T23:59:59+00:00
Accession:  0001438133-25-000072
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Tandem Diabetes receives FDA 510(k) clearance for SteadiSet infusion set (3-day use); plans 7-day submission
--------------------------------------------------------------------------------

- FDA cleared SteadiSet infusion set for up to 3 days of use; submission by subsidiary CapBio.
- SteadiSet features integrated inserter with hidden needle for one-handed insertion; for adults with Type 1 diabetes.
- Tandem intends to submit separate 510(k) to extend use to up to 7 days; commercial activities delayed until clearance.
- No immediate revenue impact; commercial launch deferred pending 7-day clearance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1438133/000143813325000072/0001438133-25-000072-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1438133/000143813325000072/tndm-20250509.htm
  HTML page:      https://secwatch.observer/filing/0001438133-25-000072

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer